Showing results (131-140 of 183) with videos related to
Sort By:
Pageof 19
Cell Stress & Chaperones|May 10, 2008
An animal model to evaluate the function and regulation of the adaptively evolving stress protein SEP53 in oesophageal bile damage responsesLenny Nelson, Susan Anderson, Alan L Archibald, et al.Ecology|May 26, 2012
Temporal turnover in the composition of tropical tree communities: functional determinism and phylogenetic stochasticityNathan G Swenson, James C Stegen, Stuart J Davies, et al.Neuro-Oncology|September 28, 2015
Combination viroimmunotherapy with checkpoint inhibition to treat glioma, based on location-specific tumor profilingJulia V Cockle, Karishma Rajani, Shane Zaidi, et al.Nature Medicine|December 11, 2007
Purging metastases in lymphoid organs using a combination of antigen-nonspecific adoptive T cell therapy, oncolytic virotherapy and immunotherapyJian Qiao, Timothy Kottke, Candice Willmon, et al.Science Advances|June 5, 2026
Engagement of the TCR against an oncolytic virus generates a population of effector CAR T cells with potent antitumor activityOlivia Liseth, Elizabeth Appleton, Benjamin Kendall, et al.Nature Medicine|November 19, 2013
Detecting and targeting tumor relapse by its resistance to innate effectors at early recurrenceTimothy Kottke, Nicolas Boisgerault, Rosa Maria Diaz, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|December 30, 2014
Mutated BRAF Emerges as a Major Effector of Recurrence in a Murine Melanoma Model After Treatment With Immunomodulatory AgentsShane Zaidi, Miran Blanchard, Kevin Shim, et al.Research Square|December 4, 2023
Chimerization of the Anti-Viral CD8+ T Cell Response with A Broad Anti-Tumor T Cell Response Reverses Inhibition of Checkpoint Blockade Therapy by Oncolytic VirotherapyRichard Vile, Mason Webb, Jacob van Vloten, et al.Cancer Immunology Research|October 18, 2017
Subversion of NK-cell and TNFα Immune Surveillance Drives Tumor RecurrenceTim Kottke, Laura Evgin, Kevin G Shim, et al.Molecular Therapy Oncolytics|June 14, 2023
Trap and ambush therapy using sequential primary and tumor escape-selective oncolytic virusesMason J Webb, Timothy Kottke, Benjamin L Kendall, et al.Pageof 19